In this study, we did not find a protective effect in univariable and multivariable comparisons for centromeric or telomeric KIR haplotype B versus A motifs in a contemporary cohort of patients with MDS of equal size (see Table 2 and Figure 3). This evidence concerns the gene KIR3DL1 and myelodysplastic syndrome.